Physician profile
Victor E Herry
NPI 1073642625
$12,264.05
in general payments reported to CMS, 2019-2025
51 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $1,656 · 2021: $1,573 · 2022: $3,212 · 2023: $1,519 · 2024: $1,504 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,451 · Education: $7.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,451.28 |
| Education | $7.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,659.25 | 2019-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $1,918.30 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,760.29 | 2019-2025 | Tezspire, Farxiga, Airsupra |
| Lilly USA, LLC | $861.54 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $527.75 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $507.19 | 2019-2025 | Tezspire, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.92 | 2019-2025 | Jardiance, Tradjenta |
| Sanofi-Aventis U.S. LLC | $391.89 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $387.07 | 2022-2025 | |
| Pfizer INC. | $231.71 | 2019-2025 | |
| Boston Scientific Corporation | $207.49 | 2023-2025 | Cds - Mct/Cem Monitoring, Bodyguardian |
| Exact Sciences Corporation | $202.00 | 2023-2025 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $201.32 | 2023-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $197.51 | 2019-2021 | |
| Abbvie INC. | $184.90 | 2021-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Herry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.